Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Gibbons

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Child Neurology|December 21, 2018
An Objective Method for Evaluating Next-Generation Sequencing PanelsKaitlin Angione, Melissa Gibbons, Scott Demarest
Military Medicine|April 11, 2018
A Fast-Running, End-to-End Concussion Risk Model for Assessment of Complex Human Head KinematicsPi Phohomsiri, Melissa Gibbons, Vladislav Volman, et al.
Pediatrics|October 3, 2018
Psychosocial Management of the Patient With Duchenne Muscular DystrophyMary K Colvin, James Poysky, Kathi Kinnett, et al.
Epilepsy Research|May 25, 2023
Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implicationsDylan C Brock, Megan Abbott, Laurel Reed, et al.
The Journal of Biological Chemistry|September 10, 2010
Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPKYanbin Zheng, Yi D Zhao, Melissa Gibbons, et al.
International Journal of Neonatal Screening|April 23, 2024
Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn ScreeningMei Lietsch, Kee Chan, Jennifer Taylor, et al.
Development (Cambridge, England)|May 26, 2009
Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during developmentNatalie E Freeman-Anderson, Yanbin Zheng, Amy C McCalla-Martin, et al.
Muscle & Nerve|October 7, 2024
Outcomes of early-treated infants with spinal muscular atrophy: A multicenter, retrospective cohort studyNatalie L Goedeker, Amanda Rogers, Mark Fisher, et al.
Orphanet Journal of Rare Diseases|June 30, 2017
Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxiaJessica L Zambonin, Allison Bellomo, Hilla Ben-Pazi, et al.
Nature Communications|May 8, 2021
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorderSukhleen Kour, Deepa S Rajan, Tyler R Fortuna, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Child Neurology|December 21, 2018
An Objective Method for Evaluating Next-Generation Sequencing PanelsKaitlin Angione, Melissa Gibbons, Scott Demarest
Military Medicine|April 11, 2018
A Fast-Running, End-to-End Concussion Risk Model for Assessment of Complex Human Head KinematicsPi Phohomsiri, Melissa Gibbons, Vladislav Volman, et al.
Pediatrics|October 3, 2018
Psychosocial Management of the Patient With Duchenne Muscular DystrophyMary K Colvin, James Poysky, Kathi Kinnett, et al.
Epilepsy Research|May 25, 2023
Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implicationsDylan C Brock, Megan Abbott, Laurel Reed, et al.
The Journal of Biological Chemistry|September 10, 2010
Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPKYanbin Zheng, Yi D Zhao, Melissa Gibbons, et al.
International Journal of Neonatal Screening|April 23, 2024
Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn ScreeningMei Lietsch, Kee Chan, Jennifer Taylor, et al.
Development (Cambridge, England)|May 26, 2009
Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during developmentNatalie E Freeman-Anderson, Yanbin Zheng, Amy C McCalla-Martin, et al.
Muscle & Nerve|October 7, 2024
Outcomes of early-treated infants with spinal muscular atrophy: A multicenter, retrospective cohort studyNatalie L Goedeker, Amanda Rogers, Mark Fisher, et al.
Orphanet Journal of Rare Diseases|June 30, 2017
Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxiaJessica L Zambonin, Allison Bellomo, Hilla Ben-Pazi, et al.
Nature Communications|May 8, 2021
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorderSukhleen Kour, Deepa S Rajan, Tyler R Fortuna, et al.
Pageof 1